Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-18
2011-01-18
Havlin, Robert (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07872139
ABSTRACT:
This invention relates to compounds of formula (I)which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
REFERENCES:
patent: 3734923 (1973-05-01), Dowding et al.
patent: 3862163 (1975-01-01), Boroschewski et al.
patent: 3874873 (1975-04-01), Volpp et al.
patent: 3887709 (1975-06-01), Brzozowski et al.
patent: 3967950 (1976-07-01), Kano et al.
patent: 4153710 (1979-05-01), Brzozowski et al.
patent: 4160833 (1979-07-01), Diel
patent: 4174398 (1979-11-01), Regel et al.
patent: 4175081 (1979-11-01), Driscoll
patent: 4183856 (1980-01-01), Makisumi et al.
patent: 4241072 (1980-12-01), Bolhofer
patent: 4243404 (1981-01-01), Kruger et al.
patent: 4405644 (1983-09-01), Kabbe et al.
patent: 4694004 (1987-09-01), Nakaguti et al.
patent: 4808722 (1989-02-01), Henrie
patent: 5262415 (1993-11-01), Takemoto et al.
patent: 5371086 (1994-12-01), Takemoto et al.
patent: 5556969 (1996-09-01), Chambers et al.
patent: 5846985 (1998-12-01), Murugesan
patent: 5846990 (1998-12-01), Murugesan et al.
patent: 5849732 (1998-12-01), Suzuki et al.
patent: 5849769 (1998-12-01), Lind et al.
patent: 5891917 (1999-04-01), Tang et al.
patent: 5935993 (1999-08-01), Tang et al.
patent: 6001860 (1999-12-01), Hamanaka
patent: 6140343 (2000-10-01), DeNinno et al.
patent: 6180635 (2001-01-01), Cheshire et al.
patent: 6225346 (2001-05-01), Tang et al.
patent: 6268384 (2001-07-01), Novak et al.
patent: 6271248 (2001-08-01), Murugesan et al.
patent: 6384220 (2002-05-01), Corbett et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 6486184 (2002-11-01), Kester et al.
patent: 6489478 (2002-12-01), DeNinno et al.
patent: 6500817 (2002-12-01), Fischer et al.
patent: 6559168 (2003-05-01), Marfat et al.
patent: 6608218 (2003-08-01), Kester et al.
patent: 6720347 (2004-04-01), Rawlins et al.
patent: 6720427 (2004-04-01), Sanner et al.
patent: 6784198 (2004-08-01), Pevarello et al.
patent: 6863647 (2005-03-01), Pevarello et al.
patent: 6875760 (2005-04-01), Lau et al.
patent: 6903125 (2005-06-01), Kontani et al.
patent: 6916814 (2005-07-01), Moss et al.
patent: 6936629 (2005-08-01), Kong et al.
patent: 7056942 (2006-06-01), Hildesheim et al.
patent: 7196104 (2007-03-01), Askew et al.
patent: 7384967 (2008-06-01), Polisetti et al.
patent: 7582769 (2009-09-01), Murray et al.
patent: 2002/0198200 (2002-12-01), Kester et al.
patent: 2003/0171411 (2003-09-01), Kodra et al.
patent: 2003/0220350 (2003-11-01), Lau et al.
patent: 2004/0014789 (2004-01-01), Lau et al.
patent: 2004/0014968 (2004-01-01), Bizzarro et al.
patent: 2007/0054897 (2007-03-01), Murray et al.
patent: 2009/0216013 (2009-08-01), Murray et al.
patent: 29937 (1972-12-01), None
patent: 2416229 (2007-09-01), None
patent: 100506807 (2009-07-01), None
patent: 1901501 (1969-08-01), None
patent: 2040580 (1971-04-01), None
patent: 2117807 (1971-10-01), None
patent: 2129418 (1971-12-01), None
patent: 2228890 (1972-12-01), None
patent: 2151766 (1973-04-01), None
patent: 2431801 (1975-01-01), None
patent: 2264983 (1975-10-01), None
patent: 2712630 (1978-09-01), None
patent: 0129408 (1984-12-01), None
patent: 0432040 (1991-06-01), None
patent: 0885890 (1998-12-01), None
patent: 0979823 (2000-02-01), None
patent: 1211246 (2002-06-01), None
patent: 1169312 (2004-10-01), None
patent: 7.428 (1968-05-01), None
patent: 2001083 (1969-09-01), None
patent: 2215967 (1974-08-01), None
patent: 771147 (1957-03-01), None
patent: 1185540 (1970-03-01), None
patent: 1195672 (1970-06-01), None
patent: 1282308 (1972-07-01), None
patent: 1318291 (1973-05-01), None
patent: 0200396 (2002-07-01), None
patent: 64056660 (1989-03-01), None
patent: 4334374 (1992-11-01), None
patent: 6016621 (1994-01-01), None
patent: 6102611 (1994-04-01), None
patent: 2002-536056 (2002-10-01), None
patent: 2021258 (1994-10-01), None
patent: WO 91/04027 (1991-04-01), None
patent: WO 93/24458 (1993-12-01), None
patent: WO 94/14801 (1994-07-01), None
patent: WO 97/24328 (1997-07-01), None
patent: WO 99/24035 (1999-05-01), None
patent: WO 99/24416 (1999-05-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 99/62890 (1999-12-01), None
patent: WO 00/17165 (2000-03-01), None
patent: WO 00/26186 (2000-05-01), None
patent: WO 00/26203 (2000-05-01), None
patent: WO 00/45742 (2000-08-01), None
patent: WO 00/53591 (2000-09-01), None
patent: WO 00/58293 (2000-10-01), None
patent: WO 01/00206 (2001-04-01), None
patent: WO 01/44216 (2001-06-01), None
patent: WO 01/44217 (2001-06-01), None
patent: WO 01/57008 (2001-08-01), None
patent: WO 01/83465 (2001-11-01), None
patent: WO 01/83478 (2001-11-01), None
patent: WO 01/85706 (2001-11-01), None
patent: WO 01/85707 (2001-11-01), None
patent: WO 02/08209 (2002-01-01), None
patent: WO 02/14311 (2002-02-01), None
patent: WO 02/46173 (2002-06-01), None
patent: WO 02/070494 (2002-09-01), None
patent: WO 03/055482 (2003-07-01), None
patent: WO 03/070727 (2003-08-01), None
patent: WO 2004/002481 (2004-01-01), None
patent: WO 2004/085388 (2004-10-01), None
patent: WO 2005/066145 (2005-07-01), None
patent: WO 2005/103050 (2005-11-01), None
patent: WO 2007/006814 (2007-01-01), None
patent: WO 2008/084043 (2008-07-01), None
patent: WO 2008/084044 (2008-07-01), None
National Institutes of Health Consensus, Ann. Int. Med., vol. 103, pp. 147-151, 1985.
Mann, G.V., N. Eng. J. Med., vol. 291(5), pp. 226-232, 1974.
Machine Translation of DE2264983.
Machine Translation of DE2228890.
Machine Translation of DE2151766.
Machine Translation of DE2040580.
Machine Translation of FR7.428M.
Machine Translation of JP6102611.
Abstract of JP 6016621.
Machine Translation of JP4334374.
Evans, et al., 1986, “Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, No. 13, Juillet 1986, USA pages.
Atwal et al., 1996, “Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers 4 Structure-Activity Studies on Benzopyranylcyanoguanidines: Replacement of the Benzopyran Portion,” Journal of Medicinal Chemistry 39:304-313.
Chipkin et al., 1994, “Hormone-Fuel Interralationships . . . ” Joslin's Diabetes 97-115.
Castelhano et al., 2005, “Glucokinase-Activating Ureas,” Bioorganic & Medicinal Chemistry Letters 15:1501-1504.
Colowick, 1973, “The Hexokinases,” The Enzymes 9: 1-48.
Decombe, 1932, “Acylacetic Esters,” Annali Di Chimica Applicata 18:81-187.
English Translation of Decombe, 1932, “Acylacetic Esters,” Annali Di Chimica Applicata 18:81-187.
Ferre et al., 1996, “Evidence From Transgenic Mice That . . . ” The Faseb Journal 10:1213-1218.
Gardner, 1948, “The Polyoxyphenol Series III Syntheses of . . . ” Canadian Journal of Research 26b:681-693.
Girard et al., 1997, Annual Review of Nutrition 17:325-352.
Glaser et al., 1998, “Familial Hyperinsulinism . . . ” The New England Journal of Medicine 338:226-230.
Grassie et al., 1950, “Preliminary Test On Possible New Stabilizers . . . ” Canadian Journal of Research 28b:468-484.
Grupe et al., 1995, “Transgenic Knockouts Reveal . . . ” Cell 83:69-78.
Goerdeler et al., 1980, “Acylcarbodiimides. IV. Preparation and Some Reactions of Carbamoylcarboiimides,” Hcaplus, Accession No. 585914.
Heitmeier et al., 1964, “Hydroxyphenethylamino Derivatives of Various Nitrogen Heterocycles,” Journal of Medicinal Chemistry 7(3):288-293.
Liang, et al., 1995, “Variable Effects of Maturity-Onset-Diabetes- of Youth,” Biochemistry 309:167-173.
Meglasson, et al., 1984, “New Perspectives On . . . ” American Journal of Physiology 246:E1-E13.
Mylari et al., 2003, “Design and Synthesis of a Novel Family of Triazine-Based Inhibitors of Sorbitol Dehydrogenase with Oral Activity: 1-{4- [3R,5S-Dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]tri
Andrews Robert Carl
Ankersen Michael
Christen Daniel P.
Cooper Jeremy T.
Jeppesen Lone
Havlin Robert
Novo Nordisk A S
Wilk-Orescan Rosemarie R.
LandOfFree
Heteroaryl-ureas and their use as glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaryl-ureas and their use as glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl-ureas and their use as glucokinase activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679901